Labcorp’s Q2 earnings smashed expectations with $3.73 billion in revenue and a boosted full-year forecast to $14.77 billion, driven by explosive growth in oncology and neurology testing plus rising demand for consumer-initiated health tests fueled by digital tools and expanded insurance coverage. The company is doubling down on high-growth specialties, expanding consumer offerings, securing global military contracts, and streamlining operations via its Launchpad initiative—all while staying resilient amid regulatory uncertainty.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
